dpp-4 inhibitor with glp-1 receptor agonist combination not recommended ada agonists or inhibitors: How to guide the clinician? Dipeptidyl Peptidase 4 Inhibitors: Novel
Description
Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): a randomized, open-label, multinational, phase 3b trial
95% CI 17.86, 0.52), metformin (WMD: 9.14
PubMedPMC 86
According to the company's cancellation policy, orders may be canceled for a full refund before medication is processed by the partner pharmacy
It measures a 50% reduction in tender and swollen joint counts, plus 50% improvement in 3 of 5 related criteria
